Z. Sheng Guo
University of Pittsburgh Cancer Institute
University of Pittsburgh School of Medicine
Pittsburgh
PA 15213
USA
Name/email consistency: high
- Homeobox gene Rhox5 is regulated by epigenetic mechanisms in cancer and stem cells and promotes cancer growth. Li, Q., O'Malley, M.E., Bartlett, D.L., Guo, Z.S. Mol. Cancer (2011)
- The combination of immunosuppression and carrier cells significantly enhances the efficacy of oncolytic poxvirus in the pre-immunized host. Guo, Z.S., Parimi, V., O'Malley, M.E., Thirunavukarasu, P., Sathaiah, M., Austin, F., Bartlett, D.L. Gene Ther. (2010)
- Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses. Guo, Z.S., Thorne, S.H., Bartlett, D.L. Biochim. Biophys. Acta (2008)
- Gene transfer: the challenge of regulated gene expression. Guo, Z.S., Li, Q., Bartlett, D.L., Yang, J.Y., Fang, B. Trends. Mol. Med (2008)
- De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model. Guo, Z.S., Hong, J.A., Irvine, K.R., Chen, G.A., Spiess, P.J., Liu, Y., Zeng, G., Wunderlich, J.R., Nguyen, D.M., Restifo, N.P., Schrump, D.S. Cancer Res. (2006)